Leading the Psychedelic Medicine Revolution With
Advancing Psychedelic & CNS Science from Jacksonville Beach
Where rigorous clinical research meets thoughtful "set & setting."
80+ years across pain, CNS & psychedelic trials
Seasoned oversight, fewer surprises
Sound-dampened, light-tunable, medically monitored
Optimal safety & participant experience
Sister-site Bold City Clinical Research
Instant operational scalability
Three decades in Business Dev/Clinical Operations for CNS & psychedelic programs. Personal Ibogaine story fuels her sponsor network—from emerging biotechs to Big Pharma.
Interventional pain & PM&R physician; founder/CEO of Formoso Pain Specialists, PA. Brings thousands of procedure hours and deep FDA-facing experience to every protocol.
Board-certified psychiatrist, assistant professor (LSU Health Shreveport). Leads psychedelic curricula and C-L services; PI on multiple MDMA & psilocybin studies.
20-year clinical-research veteran. Known for spotless monitoring visits and excellent participant retention. Has been recognized by study sponsors as a high-enrolling site in multiple clinical trials across >100 studies.
Double board-certified (Adult & Child/Adolescent Psychiatry). Local leader in ketamine-assisted therapy and holistic psychiatric care.
20-year healthcare-operations leader. Partner at FCRC and VP Ops at Formoso Spine & Joint Pain Specialists, he scales multi-site practices and fuels psychedelic & CNS trials with data-driven efficiency.
Need a full-CV or GCP cert? Just ask—happy to provide.
Scientific Advisor
Professor, University of Alabama at Birmingham
School of Public Health
"I have known Angela Hargrove for almost 2 years, and count her as one of my most trusted colleagues. She is passionate about drug development, enthusiastic but objective and measured around psychedelics, and caring and empathic toward patient populations. Critically, her business acumen in the domain of clinical trials is unmatched, and she carries herself with the utmost integrity. There's no one better positioned to assume a leadership role in the field."
Psilocybin, MDMA, DMT, Ketamine, and next-gen analogues
Depression, PTSD, anxiety, neuropathic pain, Alzheimer's Disease
Proof-of-concept to post-marketing
Robust patient database + beachside community outreach
DEA Schedule I licensing experience
Coastal palette, adjustable circadian lighting, spa-like atmosphere
Telepsychiatry for seamless follow-up care
Continuous vital-sign monitoring adjacent but out of view
30 min from JAX airport; free parking; discrete patient entrance
Reduce uncertainty in your next psychedelic or CNS trial?
Email [email protected] or call (859) 537-4238 to lock in startup dates.
1361 13th Ave S, Unit 250
Jacksonville Beach, FL 32250
(859) 537-4238
Curious about joining a clinical trial?
Add your email below and we'll send gentle, no-spam updates when a new study opens that might fit you.
Your privacy matters—information is kept strictly confidential and never shared.
